Back
MoonLake Immunotherapeutics Vs. Novartis AG Industry Stock Comparison
Sell
39
MLTX
MoonLake Immunotherapeutics
Last Price:
46.48
Seasonality Move:
18.28%
Buy
59
NVS
Novartis AG
Last Price:
110.53
Seasonality Move:
2.41%
Sell
39
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $46.76. The Score for MLTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MLTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $109.35. The Score for NVS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $46.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing selling pressure, which indicates risk of future bearish movement.
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.82 | Sell |
| Relative Strength Index (14 RSI): | 43.6 | Sell |
| Chaikin Money Flow: | 51270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.8 - 51.14) | Sell |
| Bollinger Bands (100): | (42.72 - 50.4) | Buy |
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 33.68 | Sell |
| Chaikin Money Flow: | -956964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.85 - 116.37) | Sell |
| Bollinger Bands (100): | (108.34 - 116.88) | Sell |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47 | Sell |
| 20-day SMA: | 48.43 | Sell |
| 50-day SMA: | 49.19 | Sell |
| 200-day SMA: | 47.35 | Sell |
| 8-day EMA: | 47.23 | Sell |
| 20-day EMA: | 48.16 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 46.78 | Sell |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.85 | Sell |
| 20-day SMA: | 113.97 | Sell |
| 50-day SMA: | 115.73 | Sell |
| 200-day SMA: | 106.46 | Buy |
| 8-day EMA: | 111.38 | Sell |
| 20-day EMA: | 113.27 | Sell |
| 50-day EMA: | 113.94 | Sell |
| 200-day EMA: | 108.15 | Buy |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.76 per share.
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
MoonLake Immunotherapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||